Pipeline Summary

Code Use
WC01/001 Cancerous wounds such as ulcerating breast cancer wounds and skin cancer. Demonstrated complete healing of extensive septic advanced breast cancer wound. New cancer drug development potential.
CV01/002 Hypertension – prevention and treatment. Being developed for early market entry as a herbal tea-bag. Formal drug formulation development potential.
WC02/003 Skin ulcers – venous ulcers, bed sores, difficult skin lesions. Developmental potential: OTC wound care product AND formal drug development potential. Commercial potential: strong method-of-use patent.
DC01/004 Dental carries- septic gum disease and severe toothache **Instant Analgesic action, Antimicrobial and Anti-inflammatory action. Commercial potential: herbal mouthwash and toothpaste development
CO04/046 Desicated diet soup. Balanced nutritious contents.
RP01/005 Asthmatic attack. Boiled leaf vapour preparation inhaled.
MU01/006 Severe urticarial/hypersensitive skin rash. Extensive skin allergy. Cases of "weeping" severe skin rash healed instantly.
UR01/007 Genital ulcers – drug resistant/intractable.
GY01/008 Uterus -vaginal discharge, severe pelvic inflammatory disease.
GI01/009 Diarrhoea – severe.
GI02/010 Abdominal pain, billiousness, need for emesis.
GI03/011 Diarrhoea – severe.
GI04/012 Constipation and loss of appetite in severe systemic illness such as cancer or AIDS.
MU02/013 Neonatal rash. Generalised, non-pustular, red skin rash. Probably allergic initially but if untreated often results in life-threatening purulent rash with fever. Leaf extract (red/pink) used in bath water.
GY02/014 Vaginal tightening and lubrication. Complaint that "vagina is too big and/or loose".
GY03/015 Vaginal tightening and lubrication. Complaint that "vagina is too big and/or loose".
RP01/016 Relief of dry cough and impacted mucus in babies 2-3 months old. Potent and safe mucolytic expectorant agent.
GI05/017 Loss of appetite and bedridden state in severe illness. Used in cachectic patients such as Cancer and HIV patients.
VM01/018 Prevention and treatment of Newcastle disease in chickens. Coccidiosis. Source plant has been shown to have immunomodulatory/immuneboosting and anti-microbial activity. Great potential in the poultry industry. Poultry-sparing potential in cases of Newcastle Disease epidemics known as "magic".
UR02/019 Treatment resistant and recurrent purulent urethral discharge and genital ulcer disease. Combination of 2 tree products for topical and oral use.
DE01/020 Septic skin rashes and wounds. Highly effective anti-septic with great commercial OTC potential. Also good potential for new conventional antibiotic development.
GY04/021 Loose vagina.Tried and tested and very popular . Great commercial potential as an OTC product for both sexual enhancement and vaginal mucosa health. Gynaecologist use potential, post partum. And to address a common sexual health problem among women.
PS01/022 Panic attacks, palpitations and anxiety. Herbal tea given as preparation for the delivery of bad news in persons known to be jittery or prone to hysterical response. Calming effect exploited to make tribal soldiers "brave" in battle. Has demonstrable BP lowering effect.
UR03/023 Low libido, weak erections and low sperm volume. Gentle aphrodisiac with general health "tonic" effect.
GY05/024 Increases the desirability of women by making their skin moist, supple , warm and nice to cuddle. Vaginal temperature rise. Popular in secretive tribal "erotica".
GI06/025 Diarrhoea with abdominal cramps. Used in debilitating diarrhoea associated with severe systemic disease such as HIV and cancer. Useful in making home-based care manageable.
CO01/026 Mosquito repellant. Proven efficacy in preventing mosquitoes from entering spaces in which the plant’s branches are placed.
DC02/027 Mouthwash , bad breath. Excellent for intractable hallitosis. Commercial potential; OTC mouthwash, toothpaste ingredient or drink.
GI07/028 Laxative
GI07/029 Abdominal cramps; powerful antispasmodic action.
UR04/030 Sexually transmitted disease. New antibiotic development potential.*** Star new antibiotic product. Seen the efficacy. BUT risk to tree – roots used and therefore tree dying.
VM02/031 Eye pain, infection, corneal ulcer or cataract in cattle. For formal veterinary pharmaceutical product development.
GY06/032 Severe dysmenorrhoea and lower abdominal pain
AB01/033 Antibiotic oral and topical.
OP01/034 Sore and/or purulent eyes.
TX01/035 Anti-snake bite . Proven results especially on puff-adder bites in which only wound hygiene is required with no hospitalisation . Early Commercialisation potential.
WC03/036 Kaposi sarcoma. Our strongest anti-Kaposi sarcoma agent. Seen the effect on histologically confirmed HIV associated Kaposi resistant to treatment with Harare doctors noted. Skin lesions disappeared.
WC04/037 Sinus forming intractable ulcers – osteomyelitis with sinuses.
UR05/038 Aphrodisiac
WC05/039 Athletes foot. Witnessed healing of severe bilateral athletes foot.
GI08/040 Laxative
MU02/041 Severe itchy skin reaction
WC06/042 Cancerous wounds, difficult to heal wounds: vascular ulcers, sinuses.
WC07/043 Topical analgesic with antibiotic properties
UR05/044 Aphrodisiac, sexual well being
CO02/045 Chewing gum, mouthwash, toothpaste, mint-source
CO03/045 Hair straightening, shampoo. Hair relaxer.